Pfizer, BioNTech Expecting Phase III Trial Results For Booster Dose
NEW YORK - Pfizer and BioNTech are making a strong case for the authorization of a third or booster dose of the companies' Covid-19, for which they have submitted the phase I data…
NEW YORK - Pfizer and BioNTech are making a strong case for the authorization of a third or booster dose of the companies' Covid-19, for which they have submitted the phase I data…